These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6518607)

  • 1. Oxygenated sterols as inhibitors of enzymatic conversion of dihydrolanosterol into cholesterol.
    Sato Y; Sonoda Y; Morisaki M; Ikekawa N
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3305-8. PubMed ID: 6518607
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of 15-oxygenated sterols on cholesterol synthesis from 24,25-dihydrolanosterol.
    Morisaki M; Sonoda Y; Makino T; Ogihara N; Ikekawa N; Sato Y
    J Biochem; 1986 Feb; 99(2):597-600. PubMed ID: 3700366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of oxygenated lanosterol derivatives on cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Sekigawa Y; Sato Y
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):966-73. PubMed ID: 3409414
    [No Abstract]   [Full Text] [Related]  

  • 4. Solanum alkaloids as inhibitors of enzymatic conversion of dihydrolanosterol into cholesterol.
    Kusano G; Takahashi A; Nozoe S; Sonoda Y; Sato Y
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4321-3. PubMed ID: 3435956
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of oxygenated lanosterol analogs on cholesterol biosynthesis from lanosterol.
    Sonoda Y; Sato Y
    Chem Pharm Bull (Tokyo); 1983 May; 31(5):1698-701. PubMed ID: 6616720
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of lanosterol analogs on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1981 Sep; 29(9):2604-9. PubMed ID: 7349280
    [No Abstract]   [Full Text] [Related]  

  • 7. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.
    Komoda Y; Shimizu M; Sonoda Y; Sato Y
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):531-3. PubMed ID: 2743504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cholesterol biosynthesis by carbon monoxide: accumulation of lanosterol and 24,25-dihydrolanosterol.
    Gibbons GF; Mitropoulos KA
    Biochem J; 1972 Mar; 127(1):315-7. PubMed ID: 5073750
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of 32-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Obi N; Onoda M; Sakakibara Y; Sato Y
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2796-9. PubMed ID: 1464112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of lanosterol analogs with lengthened side chains and their effects on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1984 May; 32(5):1912-8. PubMed ID: 6467473
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of 27-nor-24,25-dihydrolanosterol and 23,24,25,26,27-pentanordihydrolanosterol by rat liver homogenate preparations.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):628-34. PubMed ID: 7094149
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxidative metabolism of cholesterol precursors: sensitivity to ketoconazole, an inhibitor of cytochrome P-450.
    Iglesias J; Gibbons GF
    Steroids; 1989; 53(3-5):311-28. PubMed ID: 2799848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors.
    Hajjaj H; Macé C; Roberts M; Niederberger P; Fay LB
    Appl Environ Microbiol; 2005 Jul; 71(7):3653-8. PubMed ID: 16000773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerning the role of 24,25-dihydrolanosterol and lanostanol in sterol biosynthesis by cultured cells.
    Nes WD; Norton RA; Parish EJ; Meenan A; Popják G
    Steroids; 1989; 53(3-5):461-75. PubMed ID: 2799854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete replacement of membrane cholesterol with 4,4',14-trimethyl sterols in a human T cell line defective in lanosterol demethylation.
    Buttke TM; Folks TM
    J Biol Chem; 1992 May; 267(13):8819-26. PubMed ID: 1577721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathway for the conversion of dihydroagnosterol into cholesterol in rat liver.
    Tavares IA; Munday KA; Wilton DC
    Biochem J; 1977 Jul; 166(1):11-5. PubMed ID: 901410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspergillus oryzae produces compounds inhibiting cholesterol biosynthesis downstream of dihydrolanosterol.
    Hajjaj H; Duboc P; Fay LB; Zbinden I; Macé K; Niederberger P
    FEMS Microbiol Lett; 2005 Jan; 242(1):155-9. PubMed ID: 15621432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholesterol analogs on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y; Morisaki M; Ikekawa N
    Chem Pharm Bull (Tokyo); 1983 May; 31(5):1765-7. PubMed ID: 6616726
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
    Iglesias J; Gibbons GF
    Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the early reduction of the 24,25 double bond in the conversion of lanosterol to cholesterol in cerebrotendinous xanthomatosis.
    Tint GS; Salen G
    Metabolism; 1977 Jul; 26(7):721-9. PubMed ID: 865281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.